| Parsons Announces New Chief Human Resources Officer |
Globe Newswire |
03/17 |
16:30 |
| BlossomHill Therapeutics Unveils New Pan-KRAS Inhibitor Programs and Announces Upcoming Presentations at AACR Annual Meeting 2026 |
Globe Newswire |
03/17 |
16:30 |
| TransAlta Corporation Announces Conversion Results for Series A and B Preferred Shares |
Globe Newswire |
03/17 |
16:30 |
| Enara Bio to Unveil First‑in‑Class DARKFOX‑Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential for Solid Tumor Immunotherapy |
Globe Newswire |
03/17 |
16:30 |
| Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for Additional 90 Days |
Globe Newswire |
03/17 |
16:30 |
| Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026 |
Globe Newswire |
03/17 |
16:30 |
| Molecular Partners to Hold Three Poster Presentations at AACR 2026 |
Globe Newswire |
03/17 |
16:30 |
| Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting |
Globe Newswire |
03/17 |
16:30 |
| Evaxion to present new data at AACR Annual Meeting |
Globe Newswire |
03/17 |
16:30 |
| Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum |
Globe Newswire |
03/17 |
16:30 |
| Ocean Power Technologies, Inc. Announces Third Quarter Fiscal 2026 Results |
Globe Newswire |
03/17 |
16:15 |
| Longeveron Announces 2025 Full Year Financial Results and Provides Business Update |
Globe Newswire |
03/17 |
16:05 |
| Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer |
Globe Newswire |
03/17 |
16:05 |
| Cibus Reports Fourth Quarter Financial Results and Provides Business Update |
Globe Newswire |
03/17 |
16:05 |
| Comscore Reports Fourth Quarter and Full Year 2025 Results |
Globe Newswire |
03/17 |
16:05 |
| HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook |
Globe Newswire |
03/17 |
16:01 |
| SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants |
Globe Newswire |
03/17 |
16:01 |
| IZEA Achieves Record $18.9M Profitability Swing, Breaking Even on $31.2M of Revenue |
Globe Newswire |
03/17 |
16:01 |
| Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs) |
Globe Newswire |
03/17 |
16:01 |
| Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. |
Globe Newswire |
03/17 |
16:00 |
| QCI Launches Agentic QCI Resorts, Bringing On-Premise AI Execution to Casino Operations |
Globe Newswire |
03/17 |
15:59 |
| Movement Mortgage Welcomes Loan Officer Tanya Hill to the Pacific Northwest Region |
Globe Newswire |
03/17 |
15:51 |
| Portnoy Law Firm Announces Class Action on Behalf of Gartner, Inc. Investors |
Globe Newswire |
03/17 |
15:50 |
| Pomerantz Law Firm Announces the Filing of a Class Action Against ODDITY Tech Ltd. and Certain Officers – ODD |
Globe Newswire |
03/17 |
15:45 |
| Pomerantz Law Firm Announces the Filing of a Class Action Against Enphase Energy, Inc.and Certain Officers – ENPH |
Globe Newswire |
03/17 |
15:42 |
